Nephrotic Syndrome Supportive Care Protocol
Primary Stack
Core supplements with strongest evidenceLost in urine with protein; deficiency very common and worsens bone disease
May help reduce proteinuria; anti-inflammatory effects support kidney health
Supporting Studies (1)
Supporting Stack
Additional supplements for enhanced resultsLost in urine with protein; deficiency impairs immune function and wound healing
Supporting Studies (1)
Low due to vitamin D deficiency and protein loss; supports bone health
Supporting Studies (1)
Antioxidant; may help with oxidative stress in kidney disease
Supporting Studies (1)
Supports mitochondrial function and provides antioxidant protection
Supporting Studies (1)
Transferrin lost in urine; iron deficiency common
Supporting Studies (1)
Support gut health and may help reduce inflammation through gut-kidney axis
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Nephrotic syndrome is characterized by massive protein loss in urine (proteinuria), low blood protein (hypoalbuminemia), high cholesterol, and swelling (edema). It occurs when the kidney's filtering units (glomeruli) become damaged, allowing large proteins to leak through. Causes include minimal change disease (common in children), focal segmental glomerulosclerosis (FSGS), membranous nephropathy, diabetic nephropathy, and other glomerular diseases. The protein loss leads to multiple secondary problems: edema, increased infection risk, blood clots, and loss of important proteins that carry vitamins and minerals.
CRITICAL: Nephrotic syndrome requires comprehensive medical management by a nephrologist. Treatment depends on the underlying cause and may include immunosuppressive medications (corticosteroids, calcineurin inhibitors, rituximab), ACE inhibitors/ARBs to reduce proteinuria, diuretics for edema, and statins for hyperlipidemia. Blood clot prevention may be needed. Dietary sodium restriction is essential. These supplements address deficiencies caused by protein loss in urine but don't treat the underlying disease. All supplement use should be coordinated with your nephrologist.
* Vitamin D is lost in urine (bound to vitamin D binding protein) and deficiency is nearly universal in nephrotic syndrome. This leads to impaired calcium absorption and bone disease. Supplementation is essential.
* Omega-3 Fatty Acids have been shown in some studies to help reduce proteinuria. They also help with the hyperlipidemia common in nephrotic syndrome.
* Zinc is lost in urine bound to albumin. Deficiency impairs immune function, which is already compromised in nephrotic syndrome.
* Calcium absorption is impaired due to vitamin D deficiency. Adequate calcium intake is important for bone health, especially if taking corticosteroids.
* Vitamin E provides antioxidant protection.
* Coenzyme Q10 supports mitochondrial function.
* Iron - Transferrin is lost in urine, leading to iron deficiency even if iron intake is adequate.
* Probiotics may support gut health and the gut-kidney axis.
Expected timeline: Supplement benefits are ongoing supportive care. Disease response depends on underlying cause and treatment - minimal change disease often responds quickly to steroids; other causes may take longer or be resistant.
Clinical Perspective
Nephrotic syndrome: triad of proteinuria (>3.5g/day), hypoalbuminemia (<3g/dL), edema; often with hyperlipidemia. Causes: Primary glomerular diseases (minimal change, FSGS, membranous nephropathy) and secondary (diabetes, lupus, amyloid, infections, drugs). Complications: infection (loss of immunoglobulins), thromboembolism (loss of anticoagulant proteins, increased procoagulants), AKI, hyperlipidemia, malnutrition.
CRITICAL: Management: 1) Diagnose underlying cause (often kidney biopsy needed). 2) Reduce proteinuria: ACEi/ARB for all; disease-specific immunosuppression. 3) Edema: sodium restriction, loop diuretics +/- thiazide; albumin infusion if severe. 4) Hyperlipidemia: statins. 5) Thrombosis prevention: anticoagulation if high risk or serum albumin <2.0. 6) Infection prevention: vaccinations; prophylaxis if immunosuppressed. 7) Address nutritional deficiencies. Supplements are supportive - don't treat underlying disease.
* Vitamin D (B-grade): Urinary loss of VDBP. Systematic review: deficiency prevalence (PMID: 26385848). Review: kidney disease (PMID: 24295824). 2000-4000 IU daily; may need calcitriol.
* Omega-3 Fatty Acids (B-grade): Anti-inflammatory; may reduce proteinuria. Systematic review: nephrotic syndrome (PMID: 25691118). 2-4g EPA+DHA daily.
* Zinc (C-grade): Urinary loss. Study: deficiency in NS (PMID: 24890424). 25-50mg daily.
* Calcium (B-grade): Secondary to vitamin D deficiency. Review: bone health (PMID: 26167785). 500-1000mg daily.
* Vitamin E (C-grade): Antioxidant support. Review: glomerular disease (PMID: 15115521). 400-800 IU daily.
* CoQ10 (C-grade): Mitochondrial support. Review: kidney disease (PMID: 22867432). 100-200mg daily.
* Iron (C-grade): Transferrin loss. Study: iron status (PMID: 22473754). Supplement if deficient.
* Probiotics (C-grade): Gut-kidney axis. Meta-analysis: CKD (PMID: 31188476). 10-20 billion CFU daily.
Biomarker targets: Proteinuria (UPCR, 24h urine protein), serum albumin, lipid panel, vitamin D level, calcium/phosphorus, renal function (eGFR), zinc level.
Protocol notes: Sodium restriction: <2g/day essential for edema control. Protein intake: controversy - moderate intake (0.8-1g/kg) plus lost protein; avoid high protein (may worsen proteinuria). Diuretics: loop diuretics mainstay; resistance common due to albumin binding in tubular fluid - use higher doses or IV albumin followed by diuretic. Steroids (for MCD, some FSGS): cause bone loss, need calcium/vitamin D. Anticoagulation: consider if albumin <2.0-2.5 or other risk factors. Immunizations: pneumococcal, influenza important (infection risk elevated). Avoid NSAIDs (worsen kidney function). Statin therapy: cardiovascular risk elevated. Monitoring: frequent during active disease. Minimal change disease: excellent prognosis with steroids but relapses common. FSGS: variable; may progress to ESRD. Membranous: spontaneous remission possible; if not, immunosuppression.